ArticleLeukemia2025
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants.
Aldo A Acosta-Medina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleLeukemia2025
Aldo A Acosta-Medina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.